Prebiotic fibre supplementation in type 1 diabetes
Summary
This study will provide important information about the potential for a dietary fibre supplement to improve glucose control (highs and lows in blood glucose) in patients who have been diagnosed with type 1 diabetes. In this study we will randomize (like a flip of a coin) participants with type 1 diabetes to receive either the prebiotic fibre powder or a non-active ingredient (placebo). The study is 6 months long and you would have to complete some questionnaires and provide stool, blood and urine samples.
Eligibility
Eligible ages: 7 to 45
Inclusion criteria:
You could be part of this study if you:
• Have been diagnosed with type 1 diabetes
• Are 7 years of age or older
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
Dr. Raylene Reimer
Principal investigator:
Carol Huang
Clinical trial:
Yes
REB-ID:
REB21-0852